NEW YORK (GenomeWeb) – The National Cancer Institute Office of Cancer Clinical Proteomics Research has announced that it is seeking proposals from groups interested in producing affinity binders for its Antibody Characterization Program.

The program aims to improve reproducibility in biomedical research by providing the scientific community with well-characterized and analytically validated renewable affinity reagents with unique specificities or functions for particular applications, according to the NCI.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times and ProPublica say that many physicians fail to disclose their financial ties when publishing in medical journals.

The Wall Street Journal reports Human Longevity's valuation has dropped by 80 percent.

Science reports that the US National Cancer Institute is cutting its operating budget by 5 percent.

In PLOS this week: similar variants seen in bullbogs, people with Robinow syndrome; ApoE genotypes in African-American, Puerto Rican populations; and more.